Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Knobil Katharine, Director. Officer active across 1 company, notably Arena Pharmaceuticals INC. Cumulatively, 3 reports have been logged. History available since 11 June 2021. The latest transaction was filed on 11 June 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Katharine Knobil is a Board Member at ARENA PHARMACEUTICALS INC. She brings valuable expertise in the pharmaceutical and biotechnology sectors. As a board member, she is involved in overseeing operations and making strategic decisions to support innovation and research. Her experience in the field is a significant asset to the company.